COMMUNIQUÉS West-GlobeNewswire

Innovation Pharmaceuticals Provides Corporate Update Highlighting Clinical Pipeline Progress and Business Development Activities

29/07/2019 - 15:30

Company building on momentum from recently executed licensing agreement with Alfasigma S.p.A. Focus on transitioning to oral formulations of first-in-class drug candidates, and securing additional strategic alliances [...]

Generex Biotechnology Provides Guidance on 1:1 Stock Dividend

29/07/2019 - 15:25

Filing of up-list application to Nasdaq Details on 1:1 Shareholder stock dividend Recording and transcript of shareholders conference call available at www.generex.com MIRAMAR, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- [...]

Merit Medical to Participate at Canaccord Genuity and Needham Conferences

29/07/2019 - 15:25

SOUTH JORDAN, Utah, July 29, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

DiaResQ Rescues Children from Diarrhea

29/07/2019 - 15:20

BOULDER, Colo., July 29, 2019 (GLOBE NEWSWIRE) -- According to The World Health Organization, pediatric diarrhea is completely preventable but still takes the lives of more children under the age of 5 than AIDS, malaria [...]

Salarius Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell

29/07/2019 - 15:02

HOUSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced that President and Chief Executive [...]

BioNovelus Announces Removal of Stop Sign

29/07/2019 - 15:00

POTOMAC, Md., July 29, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (OTC: ONOV) announces it has submitted all necessary documentation to qualify as a “Limited Information” company on the OTC Markets . BioNovelus received [...]

KnippeRx™ Opens New Facility to Meet Growing Demand for its Patient-Focused Specialty Pharmacy Services

29/07/2019 - 15:00

Patient Support Center Expansion Will Further KnippeRx’s Ability to Provide Increased Speed to Therapy and Improved Patient Outcomes CHARLESTOWN, Ind., July 29, 2019 (GLOBE NEWSWIRE) -- KnippeRx Inc., a highly nimble, [...]

Taconic Biosciences Releases First Off-the-Shelf NASH Animal Model

29/07/2019 - 15:00

New Model Saves Researchers Time as They Study the Devastating Disease RENSSELAER, N.Y., July 29, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, [...]

NanoStilbene™ Nutraceutical Shown to Increase Ability of Cyclophosphamide Chemotherapy to Suppress Cancer

29/07/2019 - 15:00

Recent Data Supports Investigation of Commercially Available Product as an Adjuvant to Chemotherapy for Cancer OCEANSIDE, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- NetworkWire – Therapeutics Solutions International, Inc [...]

Transactions under Novozymes’ stock buyback program

29/07/2019 - 14:54

Please read the full announcement in the attached PDF Attachment 2019_25_Stock_Buybackprogram_EN

Ziopharm Oncology Announces $45 Million Warrant Exercise by Existing Shareholders in a Private Placement

29/07/2019 - 14:40

Provides capital to fund operations into 2021; warrant exercise in advance of November 2023 expiration BOSTON, July 29, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (“Ziopharm”) (Nasdaq: ZIOP), today announced that [...]

Allogene Therapeutics to Report Second Quarter 2019 Financial Results on August 7, 2019

29/07/2019 - 14:30

Conference Call and Webcast Scheduled for 5:30 AM PT/8:30 AM ET SOUTH SAN FRANCISCO, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company [...]

Turning Point Therapeutics Appoints Biotechnology Investment Banker Yi Larson as Executive Vice President and Chief Financial Officer

29/07/2019 - 14:30

SAN DIEGO, July 29, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today named Yi Larson as executive vice [...]

TRACON Pharmaceuticals to Participate in Wells Fargo Securities 2019 Biotech Corporate Access Day

29/07/2019 - 14:05

SAN DIEGO, July 29, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]

VBI Vaccines Announces Dosing of First Recurrent GBM Patient in Part B of Ongoing Phase 1/2a Study of VBI-1901

29/07/2019 - 14:00

— Part B of the study, a subsequent extension of the optimal dose from Part A, to enroll 10 first-recurrent GBM patients — Initial immunologic data from Part B expected around year-end 2019 — Expanded immunologic data [...]

TYME Technologies Announces New Collaboration with NYU Langone to Advance TYME’s Cancer Metabolism-Based Therapy, SM-88

29/07/2019 - 14:00

NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company, announced a new research collaboration with NYU Langone Health to advance the development of [...]

AMAG Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, August 7, 2019 at 8:00 a.m. ET

29/07/2019 - 14:00

WALTHAM, Mass., July 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2019 financial results will be released on Wednesday, August 7, 2019 before the U.S. [...]

Aggressive Growth by Commercial Medical Device Reprocessors Saved Hospitals and Health Systems Nearly $500M Last Year, According to 20th Anniversary Report from Association of Medical Device Reprocessors

29/07/2019 - 14:00

Commercial reprocessing industry saved over $471 million for 8,885 hospitals and surgical centers in 2018 Hospital uptake of commercial medical device reprocessing doubled yearly for the last 20 years Welcomed [...]

Biotricity Audited Year-End Results Demonstrate Execution of Commercial Growth Plans

29/07/2019 - 14:00

REDWOOD CITY, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. ( OTCQB : BTCY ), a medical diagnostic and consumer healthcare technology company, today announced that it has completed its 10-K filing for the [...]